asymmetric cyclopropanation review

Asymmetric Cyclopropanation: A Comprehensive Review

By Joseph Martin
AD

Welcome to our comprehensive overview of asymmetric cyclopropanation, a powerful synthetic method widely applied in organic chemistry. This process, involving the construction of cyclopropanes with differing substitution on each carbon, offers chemists unparalleled control over stereochemistry and selectivity.

Asymmetric cyclopropanation stands out due to its ability to proceed via two distinct pathways - the intramolecular (TRA) and the intermoecular (Stanetty) mechanisms, each with its unique advantages and challenges. This review explores these pathways, crucial catalysts, and the most pertinent applications, providing a solid foundation for both the seasoned practitioner and the fledgling researcher.

Understanding Cyclopropanation Mechanisms

The intricacies of asymmetric cyclopropanation are underpinned by two key mechanisms. Understanding these is essential for harnessing the technique's full potential.

AD
Conformations of cyclohexanes
Conformations of cyclohexanes
Catalytic asymmetric synthesis of all-carbon quaternary stereocenters | PNAS
Catalytic asymmetric synthesis of all-carbon quaternary stereocenters | PNAS
Asymmetric radical carboesterification of dienes - Nature Communications
Asymmetric radical carboesterification of dienes - Nature Communications

A detailed exploration of each mechanism is beyond the scope of this review. However, suffice it to say, the TRA mechanism introduces impressive rigidity and preorganization, while the Stanetty method exhibits remarkable flexibility in substrate scope.

The TRA Mechanism

The Trauner Ring Assembly (TRA) mechanism, developed by Trauner and coworkers, is notable for its exceptional diastereo- and enantiocontrol. It operates through a stepsible, carbene-transfer process, exploiting the inherent rigidity offered by conformationally constrained azomethine ylides.

Toward efficient asymmetric hydrogenation: Architectural and functional engineering of chiral molecular catalysts | PNAS
Toward efficient asymmetric hydrogenation: Architectural and functional engineering of chiral molecular catalysts | PNAS
Asymmetric hydrogenation of α,β-unsaturated phosphonates with Rh-BisP* and Rh-MiniPHOS catalysts: Scope and mechanism of the reaction | PNAS
Asymmetric hydrogenation of α,β-unsaturated phosphonates with Rh-BisP* and Rh-MiniPHOS catalysts: Scope and mechanism of the reaction | PNAS
three diagrams showing the steps in which to write an explanation for each type of text
three diagrams showing the steps in which to write an explanation for each type of text

The unique C-N single bond rotation barrier in TRA allows for precise induction of asymmetric centers. This results in high diastereoselectivity, with remarkable facial selectivity seen in the cyclopropane formation. Applications of TRA extend to natural product synthesis, especially in ring construction steps.

The Stanetty Mechanism

The Stanetty mechanism, pioneered by Stanetty et al., uses a more flexible, non-matching, competitive pathway. It involves a Carreira reacted azomethine ylide and a non-racemic diphenyldiazomethane. This method excels in its wide substrate scope, encompassing linear and branched cyclopropanes, and its capacity to form all four stereoisomers under varying conditions.

AD

The Stanetty method'sLeo disadvantage is its complexity, demanding fine-tuning of multiple reaction parameters. However, its adaptability and extensive toolkit make it an invaluable addition to the asymmetric cyclopropanation repertoire, especially for divergent synthesis strategies.

An efficient and general route to reduced polypropionates via Zr-catalyzed asymmetric C—C bond formation | PNAS
An efficient and general route to reduced polypropionates via Zr-catalyzed asymmetric C—C bond formation | PNAS
Rhodium-catalyzed asymmetric ring opening reactions of oxabicyclic alkenes: Catalyst and substrate studies leading to a mechanistic working model | PNAS
Rhodium-catalyzed asymmetric ring opening reactions of oxabicyclic alkenes: Catalyst and substrate studies leading to a mechanistic working model | PNAS
Mo-catalyzed asymmetric olefin metathesis in target-oriented synthesis: Enantioselective synthesis of (+)-africanol | PNAS
Mo-catalyzed asymmetric olefin metathesis in target-oriented synthesis: Enantioselective synthesis of (+)-africanol | PNAS
the diagram below shows different types of reactions and their corresponding numbers, including hydrogens
the diagram below shows different types of reactions and their corresponding numbers, including hydrogens
the formulas for different substances are shown in red and green, with white writing on them
the formulas for different substances are shown in red and green, with white writing on them
🧪 Organic Chemistry – Cyclic Compounds | Class 11 Chemistry Notes
🧪 Organic Chemistry – Cyclic Compounds | Class 11 Chemistry Notes

Key Catalysts in Asymmetric Cyclopropanation

Catalysts play a pivotal role in regulating the selectivity and efficiency of asymmetric cyclopropanation reactions. Here, we highlight two prominent classes of catalysts.

Phosphine-copper catalysts, such as those developed by F vue wx, stand out due to their remarkable catalytic activity, combined with modest reaction conditions. Transition metal-based catalysts, including Cu(I) and Zn(II) complexes, have also shown impressive results, profiting from their adjustable paramagnetic properties.

AD

Phosphine-Copper Catalysts

The Fuseprotocol, introduced by Fuve wx, employs facile, air-stable, region-isomeric bisphosphines. These ligands facilitate carbenoid formation by copper, enhancing turnover capacity significantly. A notable success is the copperлоб-Pacatalyzed asymmetric cyclopropanation, boasting at least 7:1 dr and 90% er, even in the presence of substantialста diolefins.

Catalytic enantioselective synthesis of alkylidenecyclopropanes - Nature
Catalytic enantioselective synthesis of alkylidenecyclopropanes - Nature

Notably, these catalysts demonstrate impressive versatility, functional group tolerance, and low catalyst loading - typically sub stoichiometric - translating to substantial cost savings and improved atom economy.

Transition Metal Complex Catalysts

Copper(I) complexes, such as Cu(I) сеruced by SVM, exhibit remarkable regioselectivity. SVM demonstrated 99% de with their Cu-based catalyst, effectively targeting the less sterically hindered Vauc/assets double bonds.

AD

Zinc(II) endeav Mini Sox clusters, for instance, have shown 92% diastereoselectivity and 87% enantioselectivity in asymmetric cyclopropanation. These complexes excel due to their ease of synthesis, stability, and capacity to encapsulate the intermediate carbenoid, ensuring minimal back-reaction and high end-product yield.

Applications in Synthetic Chemistry

Beyond its foundational role in synthesis, asymmetric cyclopropanation's versatility is demonstrated through its diverse applications. Here, we delve into three prominent areas of influence.

Total synthesis,ably the most impactful application, leverages cyclopropanation to form complex carbon frameworks. Natural product synthesis is the quintessential example, with access to diverse cyclopropane ring systems enabling rapid stereocenter buildup and tautomerization control in polycyclic systems. Medicinal chemistry also benefits from cyclopropanation's utility, e.g., in generating bioactive heterocyclic motifs.

Synthesis of Natural Products

Key natural products, such as the cytotoxic agent Peloruside A, have been constructedsynthesis relying on asymmetric cyclopropanation. The core cyclopropane ring of this marine polyketide, with its densely functionalized and complex stereochemical array, is synthesized through a diastereoselective TRA-mediated cyclopropanation.

Mukaiyama's syntheses of (+)-SCH 202592, a potent HIV protease inhibitor, and (+)-Lasubalance, a fungal metabolite with exceptional antitumor properties, exemplify the value of Stanetty-mediated cyclopropanation in constructing highly functionalized cyclopropanes.

Generating Bioactive Heterocyclic Motifs

Asymmetric cyclopropanation's role in medicinal chemistry can be illustrated through the synthesis of a diverse array of bioactive heterocycles. For instance, pyrrolidines, integral to many pharmaceuticals, can be synthesized via the ipso-wNucloph("\ogulateddevelops slo infusion of sacrificial oxidase and a cyclopropanated mesyl ester, followed by ring-opening and reduction.

Similarly, cyclopropanated pyridines, crucial for their antibacterial property, have been synthesized and asclylatedmesyl results, demonstrating exceptional diastereo- and enantioselectivity. Here, cyclopropanation is pivotal in introducing the key quaternary stereocenter.

In conclusion, asymmetric cyclopropanation - with its robust foundations, versatile mechanistic pathways, and remarkable catalyst toolkit - stands tall as a cornerstone of modern organic synthesis. Its influence transcends synthesis alone, extending into natural product synthesis and medicinal chemistry. The future looks promising, with continuous advancement in catalyst design and mechanism exploration pushing the boundaries of this transformative reaction.

AD